First pig kidney transplant patient dies 2 months after procedure

Published On 2024-05-13 12:15 GMT   |   Update On 2024-05-13 12:15 GMT
Advertisement
The first living person to receive a kidney from a genetically modified pig tragically passed away, just two months after the groundbreaking transplant. The recipient, Rick Slayman, underwent the procedure due to complications from dialysis, which required frequent hospital admissions.
Slayman viewed the transplant not only as a personal opportunity but also as a source of hope for others in need of organ transplants. His family expressed gratitude for his role in advancing xenotransplantation. Despite Slayman's optimism upon leaving the hospital after the procedure, his passing has saddened many. The transplant team at Mass General stated that there were no indications linking his death to the recent transplant. They described Slayman as a beacon of hope for transplant patients worldwide and extended heartfelt condolences to his family.
Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News